Skip to content
At the NationaLease meeting in early September, Jeff Lanza, retired FBI special agent, demonstrated how cybercrime occurs and what countermeasures businesses can take to combat the innovations of criminals. Cybercrime can affect companies of any siz ...
Dividend paying stocks like Prosegur Cash, S.A. (BME:CASH) tend to be popular with investors, and for good reason......
Roche's bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on Monday when the Swiss drugmaker said its drug risdiplam improved motor function of patients in a key study. Roche, which plans to seek approval for the investigational medicine this year, said its SUNFISH trial demonstrated statistically significant improvements in patients aged 2-25 years with Type 2 or 3 SMA, compared to a placebo. Biogen's Spinraza, approved in 2016, lists at $750,000 in year one and $375,000 thereafter, while Novartis's Zolgensma is the costliest one-time treatment at $2.1 million....
Investors can buy low cost index fund if they want to receive the average market return. But in any diversified......
If you're interested in NV Bekaert SA (EBR:BEKB), then you might want to consider its beta (a measure of share price......
In this article we are going to estimate the intrinsic value of Fjord1 ASA (OB:FJORD) by projecting its future cash......
Q3 2019 Kontoor Brands Inc Earnings Call...
